Merck & Co., Inc. MRK
Merck & Co., Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($58.66); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Merck & Co., Inc. trades at about 18.3× earnings — below its 10-year norm (10-year range 14.7×–862.7×, median 26.5×).
Shaded band = 10-year range (14.7×–862.7×); dot = today's 18.3×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 28.1% | 26.7% | 0.6% | 24.5% | 26.8% | 17.0% | 25.2% | 14.7% | 6.0% | 9.8% |
| FCF margin | 19.0% | 28.2% | 15.2% | 24.8% | 17.8% | — | — | — | — | — |
| Return on assets | 13.3% | 14.6% | 0.3% | 13.3% | 12.3% | 7.7% | 11.7% | 7.5% | 2.7% | 4.1% |
| Return on equity | 34.7% | 36.9% | 1.0% | 31.5% | 34.1% | 27.8% | 37.9% | 23.1% | 6.9% | 9.7% |
| Debt / equity | 0.89× | 0.74× | 0.89× | 0.62× | 0.80× | 1.00× | 0.87× | 0.74× | 0.62× | 0.60× |
| Current ratio | 1.54 | 1.36 | 1.25 | 1.47 | 1.27 | 1.02 | 1.24 | 1.17 | 1.33 | 1.78 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.